Vericel Corporation (VCEL) Stock
Healthcare · Biotechnology · Member of Other US Stocks
Vericel Corporation (VCEL) closed at USD 40.25 on 2026-10-14, a change of +9.3 % over the past year, with a market capitalization of USD 2.1B.
Vericel Corporation recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 40.25 |
| 2026-10-13 | 40.30 |
| 2026-10-12 | 40.62 |
| 2026-10-09 | 40.10 |
| 2026-10-08 | 40.05 |
| 2026-10-07 | 40.74 |
| 2026-10-06 | 40.05 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Vericel Corporation key figures
- Previous close
- USD 40.25 (2026-10-14)
- 1-year change
- +9.3 %
- Market cap
- USD 2.1B
- Enterprise value
- USD 2.03B
- P/E ratio (trailing)
- 87.28
- P/E ratio (forward)
- 48.49
- EPS (trailing)
- 0.47
- EPS (forward)
- 0.85
- PEG ratio
- n/a
- Price to book
- 5.67
- Revenue growth
- 22.5 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 10.21
- Employees
- 398
- Analyst consensus (third-party)
- strong_buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Vericel Corporation
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Vericel Corporation and compare it with other stocks.
Analyze VCELAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Vericel Corporation shares.